Hämeenkyrö MSWI risk assessment: Dioxin: Difference between revisions
Jump to navigation
Jump to search
(moved from main page) |
|||
Line 142: | Line 142: | ||
|References = | |References = | ||
}} | }} | ||
====Health effects caused by dioxin exposure==== | ====Health effects caused by dioxin exposure==== | ||
Line 149: | Line 150: | ||
{{var | {{var | ||
|Name = Responses of dioxin exposure on human health at the population level | |Name = Responses of dioxin exposure on human health at the population level | ||
|Focus = Determine health effects caused by dioxin exposure {{Disclink|Ambiguity with Health effects of dioxins and PM2.5}} | |Focus = Determine health effects caused by dioxin exposure {{Disclink|Ambiguity with Health effects of dioxins and | ||
PM2.5}} | |||
|Scope = General population average considered. Accidental local releases excluded | |Scope = General population average considered. Accidental local releases excluded | ||
''(Comment: This would rather go to the variable Dioxin emissions in Hämeenkyrö).'' | ''(Comment: This would rather go to the variable Dioxin emissions in Hämeenkyrö).'' | ||
|Description = Dioxins are persistent environmental contaminants which accumulate and their elimination half life in the body is rather high (~7 years). In the exposure low doses and high doses cause totally indifferent effects. Most probable | |Description = Dioxins are persistent environmental contaminants which accumulate and their elimination half life in the body | ||
is rather high (~7 years). In the exposure low doses and high doses cause totally indifferent effects. Most probable | |||
* In this specific case it is relevant to think about health effects of long-term exposure on human population | exposures for humans from MSWI are low dioxin exposures for a long period of time, which may affect the population | ||
* Dioxins are classified as known human carcinogen by IARC; | |||
* Effects on development and endocrine functions are of more of concern than cancer. According to animal data, tolerable daily intake (TDI) is set in a range of 1-4 pg TEQs/kg bodyweight/day. | "background exposure levels" by increasing them. The most susceptible subgroups among human population are children and young | ||
|Inputs = *Dioxin emissions and in Hämeenkyrö ''(Comment: This is not actually an input, but [[#Dioxin exposure due to MSWI in Hämeenkyrö]] | |||
*[[#Background incidence rates for selected diseases and causes of death in Hämeenkyrö]] population; susceptible groups, demographic data ''(Comment: This background variable is actually missing: Anne knows about the population size, but does someone know about the background disease rates?)'' | females (women at the childbearing age and before) in addition to the subgroups in the occupational hazard or those who may | ||
get high exposures via the food (fishermen). | |||
*Health effects related to '''long-term exposure''' | |||
**impairment of the immune system | |||
**impairment of the developing nervous system | |||
**impairment of the endocrine system | |||
**impairment of reproductive functions | |||
**increased cancer risk | |||
Evindence concerning other health effects is inconsistent. | |||
* In this specific case it is relevant to think about health effects of long-term exposure on human population. Also the risk | |||
of accidental exposure is low; only if the burning process is working improperly the amount of dioxins emissions will | |||
increase. | |||
* Dioxins are classified as known human carcinogen by IARC; Evidence concerning cancer risk is mainly from animal studies, | |||
and dioxins are probably quite weak carcinogens in humans. Data exist which supports the hypothesis of hormesis type of | |||
dose-responses (Tuomisto et al., 2004) in cancer. | |||
* Effects on development and endocrine functions are of more of concern than cancer. According to animal data, tolerable | |||
daily intake (TDI) is set in a range of 1-4 pg TEQs/kg bodyweight/day. | |||
* health effetcs of low doses should be modelled from animal data and use existing human data on tooth development (eg. | |||
Alaluusua et al. 1996). For example, in a study by Miettinen et al. (2005) exposure to 0.5 μg TCDD/kg body weight on GD 15 | |||
resulted in maternal adipose tissue concentration 2185 pg/g fat. In that study linear extrapolation of the data predicts a | |||
maternal adipose tissue concentration of 100-120 pg/g fat after exposure to 0.03 μg TCDD/kg body weight. This estimated | |||
maternal adipose tissue concentration which is sufficient to induce developmental dental defects in rat offspring, is similar | |||
to the highest values measured in the Finnish average population (PCDD/F 145.5 pg WHO-TEQ/g fat, Kiviranta et al. 2005). | |||
(Miettinen, 2006) | |||
|Inputs = *Dioxin emissions and in Hämeenkyrö ''(Comment: This is not actually an input, but [[#Dioxin exposure due to | |||
MSWI in Hämeenkyrö]] | |||
*[[#Background incidence rates for selected diseases and causes of death in Hämeenkyrö]] population; susceptible groups, | |||
demographic data ''(Comment: This background variable is actually missing: Anne knows about the population size, but does | |||
someone know about the background disease rates?)'' | |||
*[[#Population size in Hämeenkyrö]] | *[[#Population size in Hämeenkyrö]] | ||
*[[#Baseline dioxin exposure in Hämeenkyrö]] | *[[#Baseline dioxin exposure in Hämeenkyrö]] | ||
|Index = | |Index = | ||
|Definition = | |Definition = | ||
|Unit = increased | |Unit = increased developmental defects/ pg/kg body weight/ year, | ||
increased | increased cancer per pg/kg body weight OR per adipose tissue concentration | ||
''(Comment: units are good for exposure-response function (as this variable used to be) but not for health effect (as it | |||
currently seems to be)'' | |||
|Result = | |Result = | ||
|References = Tuomisto JT et al. Int J Cancer. 2004 Mar 1;108(6):893-900. | |References = Tuomisto JT et al. Int J Cancer. 2004 Mar 1;108(6):893-900. | ||
Line 175: | Line 228: | ||
van Leeuwen FX et.al. Chemosphere. 2000 May-Jun;40(9-11):1095-101. | van Leeuwen FX et.al. Chemosphere. 2000 May-Jun;40(9-11):1095-101. | ||
Alaluusua et al. Eur J Oral Sci. 1996 Oct-Dec;104(5-6):493-7. | |||
Miettinen HM et al. Toxicol Sci. 2005 Jun;85(2):1003-12. | |||
Kiviranta et al. Chemosphere. 2005 Aug;60(7):854-69. | |||
}} | }} |
Revision as of 07:50, 22 September 2006
See the main page of this assessment: Hämeenkyrö MSWI risk assessment: General
Dioxin emissions in Hämeenkyrö
Virpi
Intake fraction for dioxin emissions from Hämeenkyrö
Intake fraction for dioxin emissions from Hämeenkyrö
Baseline dioxin exposure in Hämeenkyrö
Marjo
Baseline dioxin exposure in Hämeenkyrö
Dioxin exposure due to MSWI in Hämeenkyrö
Martin
Health effects caused by dioxin exposure
Sanna
Responses of dioxin exposure on human health at the population level